The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Where does everyone get their RNS from. LSE doesn’t appear to have them updated and VOX doesn’t load for me...
Any suggestions?
still too igh at 13%!
Well done to all who have held here. Use to be in KETL back in 2018 when it was around the 130p mark, sold out at 170/180p within a few months, did well or 30% profit in a few months. I remember the company having avery small free float of around 30% shares, I wonder if it is still the case, will have to update research and see where it stands.
P.S if anyone bought more in that dip in February I can imagine the smirk on your face!
Stay safe, speak soon, happy investing.
I have never had to use the block list but its getting to that stage now with some of the idiotic posts on here.
Company looks promising and is targeting highly demand areas in a short space. The COVID-19 tests will generate cash flow and no doubt when the RNS comes out saying we have CE approval the price will go up.
Have cash now due to the raising of funds at 80p so has £7,000,000 cash. Expecting to produce tests between £8-£10. Lets take a price of £6 to be more conservative with a profit margin of 40% again being more conservative than the 60% quoted. They said that they can produce 10,000 tests per hour and have a supply chain for 6 million tests. Lets again be conservative and say that they produce 5M tests (about 15%) less incase there are any faults etc
That gives 5,000,000 x £6 = 30,000,000. 40% of that equals £12,000,000 income. Thats being conservative as well. Not sure how long it takes to produce the tests... they said 10,000 an hour, again not sure if that is based on 24 hours or 8hour day. Lets say its 6 hours t be further conservative and account for any error etc that means 60,000 tests a day which would mean our capacity is done in 83 days... so within the next quarter £12,000,000 should be available... if not next 3 months at least the next 6, thats based on no further developments that will go ahead if successful. If we get the CE stamp that allows us to distribute across the European Economic Area which means greater demand.
Thats what we want. some cash flow. £8-£10 a test seems slightly excessive. but if its a 60% margin I suppose it needs to be profitable. At the end of the day it is Government money so will pay whatever the test costs, especially if it gives results in hours rather than days.
Does anybody have any guess at how much these test kits are going to be sold for.
This company looks speculatively good with what is in the pipeline. Considering they're basically tackling the poor and impoverished societies with a hand held device that can give results quickly appears to be good. A bonus is that it has WHO approval and possible CE stamp within 3 weeks means COVID-19 test can be sold across all of Europe Economic Area.
Even if you forget COVID. The upside of Iclaprim is useful for MRSA and cystic fibrosis. both ICLAPRIM AND LMS611 (Lemellar) are effective working together.
GDR have has similar situation to MTFB today. A placing at 80p and price was 250p dropped to 175p and now back up to 250p
Similar situation to MTFB.
where was it mentioned?
Buys must be going through at above 1p as Google price is fluctuating between 1.17 and 1.34?
I do not have access to L2.